 |
PDBsum entry 3b5d
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Membrane protein
|
PDB id
|
|
|
|
3b5d
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
104:18999-19004
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray structure of EmrE supports dual topology model.
|
|
Y.J.Chen,
O.Pornillos,
S.Lieu,
C.Ma,
A.P.Chen,
G.Chang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
EmrE, a multidrug transporter from Escherichia coli, functions as a homodimer of
a small four-transmembrane protein. The membrane insertion topology of the two
monomers is controversial. Although the EmrE protein was reported to have a
unique orientation in the membrane, models based on electron microscopy and now
defunct x-ray structures, as well as recent biochemical studies, posit an
antiparallel dimer. We have now reanalyzed our x-ray data on EmrE. The corrected
structures in complex with a transport substrate are highly similar to the
electron microscopy structure. The first three transmembrane helices from each
monomer surround the substrate binding chamber, whereas the fourth helices
participate only in dimer formation. Selenomethionine markers clearly indicate
an antiparallel orientation for the monomers, supporting a "dual
topology" model.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Structure determination of EmrE. (A) Experimental
density for one apo EmrE monomer at 4.5-Å resolution.
Anomalous Hg density (4 ), marking the
positions of cysteine residues, is shown in red. The protein is
shown in C^ trace and rendered in a
color gradient, from green at the N terminus to yellow at the C
terminus. (B) Ribbon representation of the distorted apo EmrE
dimer. One monomer is rendered in color gradient with the
helices labeled, and the other monomer is shown in gray. The
approximate dimensions of a lipid bilayer are shown by the gray
shading. (C) Views of the two apo EmrE monomers, with TM helices
labeled. Note the extended configuration of the TM4 helices,
which project away from the main body of the dimer. (D)
Experimental density for one monomer of the EmrE-TPP complex at
3.8 Å (C2 crystal form), contoured at 1 .
Anomalous Se density (3 ) is shown in red. (E)
Side view of the EmrE-TPP dimer (C2 form), with the dimensions
of the lipid bilayer indicated. One monomer is colored in
gradient and labeled, and the other is in gray. The bound TPP is
colored red. Density for the colored monomer terminates at
residue 105. (F) Views of the two monomers (P2[1] form), which
are essentially the same as the C2 monomers, except for the
shorter TM helices, which terminate at the indicated residues.
Full-length EmrE has 110 amino acid residues. Note that the
superhelical twists of TM1–3 are similar in the apo and
TPP-bound forms but that the helix packing interactions and
monomer–monomer interactions differ.
|
 |
Figure 3.
Fig. 3. EmrE binds TPP as an antiparallel dimer. (A)
Stereoview of the EmrE transporter in complex with TPP. The two
monomers are colored blue and yellow, and the bound TPP is pink.
Anomalous Fourier density from SeMet (colored red in one monomer
and green in the other) and the arsonium analogue of TPP
(magenta) are shown contoured at 3 and 3.5 ,
respectively. The TPP and SeMet residue positions are labeled,
with the two monomers distinguished by asterisks. (B) "Front"
view of the transporter, emphasizing the positions of SeMet
markers in TM1. The N termini of the monomers are labeled. (C)
"Top" view of the EmrE-TPP structure, with the TM helices
labeled. Red spheres indicate the positions of residues that
have been implicated in substrate binding and transport by
biochemical and mutagenesis studies (18, 20, 23–28). The only
residue removed from the binding chamber is Leu-93 (TM4). In the
x-ray crystals, this residue appears to mediate lattice
interactions across a twofold symmetry axis relating two dimers.
This crystal packing interface was also observed in the
two-dimensional crystals used to derive the EM structure of
EmrE-TPP (14).
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
E.A.Morrison,
G.T.DeKoster,
S.Dutta,
R.Vafabakhsh,
M.W.Clarkson,
A.Bahl,
D.Kern,
T.Ha,
and
K.A.Henzler-Wildman
(2012).
Antiparallel EmrE exports drugs by exchanging between asymmetric structures.
|
| |
Nature,
481,
45-50.
|
 |
|
|
|
|
 |
F.Junge,
S.Haberstock,
C.Roos,
S.Stefer,
D.Proverbio,
V.Dötsch,
and
F.Bernhard
(2011).
Advances in cell-free protein synthesis for the functional and structural analysis of membrane proteins.
|
| |
N Biotechnol,
28,
262-271.
|
 |
|
|
|
|
 |
J.D.Faraldo-Gómez,
and
L.R.Forrest
(2011).
Modeling and simulation of ion-coupled and ATP-driven membrane proteins.
|
| |
Curr Opin Struct Biol,
21,
173-179.
|
 |
|
|
|
|
 |
S.Rajesh,
T.Knowles,
and
M.Overduin
(2011).
Production of membrane proteins without cells or detergents.
|
| |
N Biotechnol,
28,
250-254.
|
 |
|
|
|
|
 |
V.H.Lam,
J.H.Lee,
A.Silverio,
H.Chan,
K.M.Gomolplitinant,
T.L.Povolotsky,
E.Orlova,
E.I.Sun,
C.H.Welliver,
and
M.H.Saier
(2011).
Pathways of transport protein evolution: recent advances.
|
| |
Biol Chem,
392,
5.
|
 |
|
|
|
|
 |
C.J.Tsai,
and
C.Ziegler
(2010).
Coupling electron cryomicroscopy and X-ray crystallography to understand secondary active transport.
|
| |
Curr Opin Struct Biol,
20,
448-455.
|
 |
|
|
|
|
 |
D.Schwarz,
D.Daley,
T.Beckhaus,
V.Dötsch,
and
F.Bernhard
(2010).
Cell-free expression profiling of E. coli inner membrane proteins.
|
| |
Proteomics,
10,
1762-1779.
|
 |
|
|
|
|
 |
K.McLuskey,
A.W.Roszak,
Y.Zhu,
and
N.W.Isaacs
(2010).
Crystal structures of all-alpha type membrane proteins.
|
| |
Eur Biophys J,
39,
723-755.
|
 |
|
|
|
|
 |
K.R.Vinothkumar,
and
R.Henderson
(2010).
Structures of membrane proteins.
|
| |
Q Rev Biophys,
43,
65.
|
 |
|
|
|
|
 |
M.Kalman,
and
N.Ben-Tal
(2010).
Quality assessment of protein model-structures using evolutionary conservation.
|
| |
Bioinformatics,
26,
1299-1307.
|
 |
|
|
|
|
 |
M.Schushan,
Y.Barkan,
T.Haliloglu,
and
N.Ben-Tal
(2010).
C(alpha)-trace model of the transmembrane domain of human copper transporter 1, motion and functional implications.
|
| |
Proc Natl Acad Sci U S A,
107,
10908-10913.
|
 |
|
|
|
|
 |
S.F.Poget,
R.Harris,
S.M.Cahill,
and
M.E.Girvin
(2010).
1H, 13C, 15N backbone NMR assignments of the Staphylococcus aureus small multidrug-resistance pump (Smr) in a functionally active conformation.
|
| |
Biomol NMR Assign,
4,
139-142.
|
 |
|
|
|
|
 |
S.Seppälä,
J.S.Slusky,
P.Lloris-Garcerá,
M.Rapp,
and
G.von Heijne
(2010).
Control of membrane protein topology by a single C-terminal residue.
|
| |
Science,
328,
1698-1700.
|
 |
|
|
|
|
 |
S.Sobhanifar,
B.Schneider,
F.Löhr,
D.Gottstein,
T.Ikeya,
K.Mlynarczyk,
W.Pulawski,
U.Ghoshdastider,
M.Kolinski,
S.Filipek,
P.Güntert,
F.Bernhard,
and
V.Dötsch
(2010).
Structural investigation of the C-terminal catalytic fragment of presenilin 1.
|
| |
Proc Natl Acad Sci U S A,
107,
9644-9649.
|
 |
|
|
|
|
 |
S.Sobhanifar,
S.Reckel,
F.Junge,
D.Schwarz,
L.Kai,
M.Karbyshev,
F.Löhr,
F.Bernhard,
and
V.Dötsch
(2010).
Cell-free expression and stable isotope labelling strategies for membrane proteins.
|
| |
J Biomol NMR,
46,
33-43.
|
 |
|
|
|
|
 |
T.A.Nguyen,
S.S.Lieu,
and
G.Chang
(2010).
An Escherichia coli-based cell-free system for large-scale production of functional mammalian membrane proteins suitable for X-ray crystallography.
|
| |
J Mol Microbiol Biotechnol,
18,
85-91.
|
 |
|
|
|
|
 |
X.He,
P.Szewczyk,
A.Karyakin,
M.Evin,
W.X.Hong,
Q.Zhang,
and
G.Chang
(2010).
Structure of a cation-bound multidrug and toxic compound extrusion transporter.
|
| |
Nature,
467,
991-994.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.E.Poulsen,
A.Rath,
and
C.M.Deber
(2009).
The assembly motif of a bacterial small multidrug resistance protein.
|
| |
J Biol Chem,
284,
9870-9875.
|
 |
|
|
|
|
 |
F.Katzen,
T.C.Peterson,
and
W.Kudlicki
(2009).
Membrane protein expression: no cells required.
|
| |
Trends Biotechnol,
27,
455-460.
|
 |
|
|
|
|
 |
K.Shimono,
M.Goto,
T.Kikukawa,
S.Miyauchi,
M.Shirouzu,
N.Kamo,
and
S.Yokoyama
(2009).
Production of functional bacteriorhodopsin by an Escherichia coli cell-free protein synthesis system supplemented with steroid detergent and lipid.
|
| |
Protein Sci,
18,
2160-2171.
|
 |
|
|
|
|
 |
N.P.Barrera,
S.C.Isaacson,
M.Zhou,
V.N.Bavro,
A.Welch,
T.A.Schaedler,
M.A.Seeger,
R.N.Miguel,
V.M.Korkhov,
H.W.van Veen,
H.Venter,
A.R.Walmsley,
C.G.Tate,
and
C.V.Robinson
(2009).
Mass spectrometry of membrane transporters reveals subunit stoichiometry and interactions.
|
| |
Nat Methods,
6,
585-587.
|
 |
|
|
|
|
 |
P.D.Jeffrey
(2009).
Analysis of errors in the structure determination of MsbA.
|
| |
Acta Crystallogr D Biol Crystallogr,
65,
193-199.
|
 |
|
|
|
|
 |
S.Balaz
(2009).
Modeling kinetics of subcellular disposition of chemicals.
|
| |
Chem Rev,
109,
1793-1899.
|
 |
|
|
|
|
 |
S.G.Aller,
J.Yu,
A.Ward,
Y.Weng,
S.Chittaboina,
R.Zhuo,
P.M.Harrell,
Y.T.Trinh,
Q.Zhang,
I.L.Urbatsch,
and
G.Chang
(2009).
Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding.
|
| |
Science,
323,
1718-1722.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.M.Blois,
and
J.U.Bowie
(2009).
G-protein-coupled receptor structures were not built in a day.
|
| |
Protein Sci,
18,
1335-1342.
|
 |
|
|
|
|
 |
U.A.Hellmich,
and
C.Glaubitz
(2009).
NMR and EPR studies of membrane transporters.
|
| |
Biol Chem,
390,
815-834.
|
 |
|
|
|
|
 |
V.M.Korkhov,
and
C.G.Tate
(2009).
An emerging consensus for the structure of EmrE.
|
| |
Acta Crystallogr D Biol Crystallogr,
65,
186-192.
|
 |
|
|
|
|
 |
X.Z.Li,
and
H.Nikaido
(2009).
Efflux-mediated drug resistance in bacteria: an update.
|
| |
Drugs,
69,
1555-1623.
|
 |
|
|
|
|
 |
D.Schwarz,
V.Dötsch,
and
F.Bernhard
(2008).
Production of membrane proteins using cell-free expression systems.
|
| |
Proteomics,
8,
3933-3946.
|
 |
|
|
|
|
 |
J.Wu,
K.A.Hassan,
R.A.Skurray,
and
M.H.Brown
(2008).
Functional analyses reveal an important role for tyrosine residues in the staphylococcal multidrug efflux protein QacA.
|
| |
BMC Microbiol,
8,
147.
|
 |
|
|
|
|
 |
K.Charalambous,
D.Miller,
P.Curnow,
and
P.J.Booth
(2008).
Lipid bilayer composition influences small multidrug transporters.
|
| |
BMC Biochem,
9,
31.
|
 |
|
|
|
|
 |
S.Reckel,
S.Sobhanifar,
B.Schneider,
F.Junge,
D.Schwarz,
F.Durst,
F.Löhr,
P.Güntert,
F.Bernhard,
and
V.Dötsch
(2008).
Transmembrane segment enhanced labeling as a tool for the backbone assignment of alpha-helical membrane proteins.
|
| |
Proc Natl Acad Sci U S A,
105,
8262-8267.
|
 |
|
|
|
|
 |
Y.Elbaz,
T.Salomon,
and
S.Schuldiner
(2008).
Identification of a glycine motif required for packing in EmrE, a multidrug transporter from Escherichia coli.
|
| |
J Biol Chem,
283,
12276-12283.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |